In conclusion, our findings highlight a previously unrecognized role of the transcription factor ZEB2 in supporting lung tumor-reactive Teff cell differentiation and the anti-tumor efficacy of CD8+ TILs in NSCLC. This evidence concerns the gene ZEB2 and neoplasm.